Financing - November 28, 2018
Cobra Biologics wins Innovate UK award
Cobra Biologics, Pall Corporation and the Cell and Gene Therapy Catapult win £1.5M innovate UK grant. Cobra Biologics has won a £1.5m shared grant from Innovate UK, the United Kingdom’s innovation agency. Co-winners, Pall Corporation and the Cell and Gene Therapy Catapult will work with Cobra Biologics to investigate continuous manufacturing of adeno-associated virus (AAV) for gene therapy applications. “In […]
Global report - September 5, 2018
A new collaboration project to improve drug safety in East Africa
Karolinska Institutet will lead an international collaboration project on pharmacovigilance, drugs safety, in four countries in East Africa. In recent years access to drugs and vaccines has been increasing in many African countries, but the systems for monitoring treatment effects and reporting side-effects require further development. PROFORMA Those taking part in the project, known as […]
Global report - August 9, 2018
Boehringer Ingelheim takes its first step into gene therapy
The company have together with the UK Cystic Fibrosis Gene Therapy Consortium (GTC), consisting of Imperial College London and the Universities of Oxford and Edinburgh, Imperial Innovations, and Oxford BioMedica (OXB) announced a global collaboration to develop a first-in-class, long-term therapy for patients with cystic fibrosis (CF). The new partnership brings together the academic partners’ […]
Global report - July 20, 2018
GE Healthcare opens cell and gene therapy center in Shanghai
GE Healthcare Life Sciences opens the company’s first cell and gene therapy laboratory in Asia, aiming to enable new developments and commercialization of precision medicine in Asia. According to the company, the center, aligned to GE Healthcare’s Fast Trak China offering, marks a milestone in GE Healthcare Life Sciences’ effort to accelerate precision health through technology and services such […]
Global report - May 29, 2018
For scientific impact, open the borders
Countries with high researcher mobility get more recognition. Governments around the world are closing borders: Look at the 2018 Italian election, the Trump administration, and Brexit. How will this trend affect R&D? Anti-immigration policies negatively affect science, says Professor Caroline Wagner, John Glenn College of Public Affairs, Ohio State University. “People who study creativity say […]
Biotech Business - April 26, 2018
Important progress for cell therapy
Nordic Life Science asked Lars Hedbys, CEO of Idogen, about the potential and challenges for cell therapies. For gene and cell therapies 2017 really was a breakthrough year. For example, there was an increasing interest in companies developing these therapies, like the recent news about Takeda’s intention to acquire TiGenix, a biopharma company developing novel stem […]
